These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12190193

  • 1. Precore stop mutant in anti-HBe-positive phases of chronic hepatitis B virus infection.
    Chu CM.
    Am J Gastroenterol; 2002 Aug; 97(8):2138-9; author reply 2139-40. PubMed ID: 12190193
    [No Abstract] [Full Text] [Related]

  • 2. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
    Maruyama T, Mitsui H, Maekawa H, Yamada H, Hirayama M, Iino S, Yasuda K, Koike K, Kimura S, Milich DR.
    Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe.
    Zhang K, Imazeki F, Fukai K, Arai M, Kanda T, Mikata R, Yokosuka O.
    J Med Virol; 2007 Jun; 79(6):683-93. PubMed ID: 17457922
    [Abstract] [Full Text] [Related]

  • 4. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
    Shanmugam S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Shankar EM, Murugavel KG, Balakrishnan P, Kumarasamy N, Solomon S, Thyagarajan SP.
    J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
    [Abstract] [Full Text] [Related]

  • 5. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ, Yoo BC.
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [Abstract] [Full Text] [Related]

  • 6. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
    Duong TN, Horiike N, Michitaka K, Yan C, Mizokami M, Tanaka Y, Jyoko K, Yamamoto K, Miyaoka H, Yamashita Y, Ohno N, Onji M.
    J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.
    Lin CL, Kao JH.
    J Biomed Sci; 2008 Mar; 15(2):137-45. PubMed ID: 18058038
    [Abstract] [Full Text] [Related]

  • 8. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
    Yamaura T, Tanaka E, Matsumoto A, Rokuhara A, Orii K, Yoshizawa K, Miyakawa Y, Kiyosawa K.
    J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [Abstract] [Full Text] [Related]

  • 12. The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus-host relationship based on molecular virology and immunopathogenesis considerations?
    Thompson A, Locarnini S, Visvanathan K.
    Gastroenterology; 2007 Sep; 133(3):1031-5. PubMed ID: 17854605
    [No Abstract] [Full Text] [Related]

  • 13. Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.
    Cheong JY, Cho SW, Yoo JH, Hong SP, Kim SO, Yoo WD, Kim JH.
    Hepatogastroenterology; 2008 Sep; 55(84):1029-33. PubMed ID: 18705323
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.
    Chen CH, Lee CM, Lu SN, Changchien CS, Wang JC, Wang JH, Hung CH, Hu TH.
    J Hepatol; 2006 Jan; 44(1):76-82. PubMed ID: 16298013
    [Abstract] [Full Text] [Related]

  • 16. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB, Naoumov NV, Gilson RJ, Tedder RS.
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria].
    Khelifa F, Thibault V.
    Pathol Biol (Paris); 2009 Feb; 57(1):107-13. PubMed ID: 18835106
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The emergence of envelope and precore/core variants of hepatitis B virus: the potential role of antibody selection.
    Thomas HC.
    J Hepatol; 1995 Feb; 22(1 Suppl):1-8. PubMed ID: 7602059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.